C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/5025 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2634721
The invention is directed to triazolopyridazine compounds of Formula (I): where R1, R5, R6, R7, R8, and A are as defined herein, the use of such compounds as protein tyrosine kinase modulators, particularly inhibitors of c-Met, and the use of such compounds to reduce or inhibit kinase activity of c-Met in a cell or a subject, and modulate c-Met expression in a cell or subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to c-Met. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as cancers and other cell proliferative disorders.
La présente invention concerne des composés de triazolopyridazine de formule (I), dans laquelle: R<SUP>1</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, et A sont tels que définis dans la description, l'utilisation de tels composés en tant que modulateurs de la protéine tyrosine kinase, notamment des inhibiteurs de c-Met, et l'utilisation de tels composés pour la réduction ou l'inhibition de l'activité kinase de c-Met dans une cellule ou chez un sujet, et l'utilisation de tels composés pour la prévention ou le traitement chez un sujet d'un trouble et/ou des troubles de prolifération cellulaire apparentés à c-Met. La présente invention concerne également des compositions pharmaceutiques comportant les composés de la présente invention et des procédés pour le traitement de pathologies telles que le cancer et d'autres troubles de prolifération cellulaire.
Alexander Richard
Connors Richard W.
Cummings Maxwell D.
Galemmo Robert A.
Hufnagel Heather Rae
Janssen Pharmaceutica N.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Triazolopyridazines as tyrosine kinase modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyridazines as tyrosine kinase modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyridazines as tyrosine kinase modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549124